Summary:
To compare the effect of glycemic control (HbA1c) of exenatide suspension administered once weekly.
Qualified Participants Must:
• Be over the age of 18
•
Have been diagnosed with type 2 diabetes
•
Be taking Metformin
•
Have a stable body weight
Qualified Participants May Receive:
Will be compendated for time and travel and will receive testing for study covered at no cost.